Who Exports Hydrocortisone from India — 597 Suppliers Behind a $65.7M Market
India's hydrocortisone export market is supplied by 597 active exporters who collectively shipped $65.7M across 6,743 shipments. STRIDES PHARMA SCIENCE LIMITED leads with a 13.9% market share, followed by LINCOLN PHARMACEUTICALS LTD and CIPLA LIMITED. The top 5 suppliers together control 36.1% of total export value, reflecting a moderately competitive market structure.
Top Hydrocortisone Exporters from India — Ranked by Export Value
STRIDES PHARMA SCIENCE LIMITED is the leading hydrocortisone exporter from India, holding a 13.9% share of the $65.7M market across 6,743 shipments from 597 exporters. The top 5 suppliers — STRIDES PHARMA SCIENCE LIMITED, LINCOLN PHARMACEUTICALS LTD, CIPLA LIMITED, CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD — collectively control 36.1% of total export value, indicating a competitive market. Individual shares are: STRIDES PHARMA SCIENCE LIMITED (13.9%), LINCOLN PHARMACEUTICALS LTD (8.2%), CIPLA LIMITED (5.4%), CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED (4.7%), MACLEODS PHARMACEUTICALS LTD (3.9%).
Top Hydrocortisone Exporters from India
Ranked by export value · 597 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED HYDROCORTISONE TABLETS USP 10MG 54 640 00 X 100 SHYDROCORTISONE TABLETS USP 10MG 54 640 00X 100 SHYDROCORTISONE TABLETS USP 5MG 78 880 00X 50 S | $9.1M | 2 | 13.9% |
| 2 | LINCOLN PHARMACEUTICALS LTD HYDROCORTISONE SODIUM SUCCINATE FOR INJEHYDROCORTISONE SODIUM SUCCINATE INJECTION USP 100MGUMICORT-100 NOS | $5.4M | 13 | 8.2% |
| 3 | CIPLA LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEHYDROCORTISONE TABLETS USP 10MG 54 640 00 X 100 SHYDROCORTISONE TABLETS USP 10MG 54 640 00X 100 S | $3.6M | 5 | 5.4% |
| 4 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEPHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP 100MG NOS | $3.1M | 22 | 4.7% |
| 5 | MACLEODS PHARMACEUTICALS LTD MACLEODS HYDROCORTISONE INJECTION 100MGPHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP 100MG NOS | $2.6M | 14 | 3.9% |
| 6 | MEPRO PHARMACEUTICALS PRIVATE LIMITED CIPLA HYDROCORTISONE 100MG INJECTION (HYCIPLA HYDROCORTISONE 100MG INJECTION(HYDHYDROCORTISONE SODIUM SUCCINATE FOR INJE | $2.5M | 9 | 3.7% |
| 7 | UMEDICA LABORATORIES PRIVATE LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEPHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP 100MG NOS | $2.1M | 11 | 3.2% |
| 8 | TROIKAA PHARMACEUTICALS LIMITED | $1.7M | 8 | 2.5% |
| 9 | KWALITY PHARMACEUTICALS LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEHYDROCORTISONE SODIUM SUCCINATE INJECTION USP 100MGINJ.LYCORTIS 100MG INJ. HYDROCORTISONE | $1.3M | 15 | 2.0% |
| 10 | BRAWN LABORATORIES LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEPHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP 100MG NOS | $1.2M | 12 | 1.9% |
| 11 | GOPALDAS VISRAM AND COMPANY LIMITED HYDROCORTISONE TABLETS USP 10MG 54 640 00 X 100 SHYDROCORTISONE TABLETS USP 10MG 54 640 00X 100 SHYDROCORTISONE TABLETS USP 5MG 78 880 00X 50 S | $1.2M | 1 | 1.9% |
| 12 | UMENDRA EXPORTS PRIVATE LIMITED HYDROCORTISONE TABLETS USP 10MG 54 640 00 X 100 SHYDROCORTISONE TABLETS USP 10MG 54 640 00X 100 SHYDROCORTISONE TABLETS USP 5MG 78 880 00X 50 S | $1.1M | 1 | 1.8% |
| 13 | LYKA LABS LIMITED HYDROCORTISONE SODIUM SUCCINATE FOR INJEPHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE INJECTION USP 100MG | $1.1M | 10 | 1.7% |
| 14 | SWISS PARENTERALS LIMITED PHARMACEUTICAL PRODUCTS - HYDROCORTISONEHYDROCORTISONE SODIUM SUCCINATE INJECTION USP 100MGHYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP 100MG NOS | $1.1M | 15 | 1.7% |
| 15 | EUGIA PHARMA SPECIALITIES LIMITED HYDROCORTISONE TABLETS USP 10MG 54 640 00 X 100 SHYDROCORTISONE TABLETS USP 10MG 54 640 00X 100 SHYDROCORTISONE TABLETS USP 5MG 78 880 00X 50 S | $1.0M | 1 | 1.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Hydrocortisone exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cipla Limited | Warning Letter (November | Unknown | Unknown | 1 | FDA issued a warning letter citing CGMP violations at Indore facility. |
| Eugia Pharma Specialities Limited | Warning Letter (August 20 | Unknown | Unknown | 3 | FDA issued a warning letter for CGMP violations at Unit III facility. |
| Strides Pharma Science Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Lincoln Pharmaceuticals Ltd | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Macleods Pharmaceuticals Ltd | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Mepro Pharmaceuticals Private Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Umedica Laboratories Private Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Troikaa Pharmaceuticals Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Kwality Pharmaceuticals Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
| Brawn Laboratories Limited | Approved | Unknown | Unknown | Unknown | FDA approval status confirmed; no warning letters found. |
TransData Nexus reviewed the regulatory standing of 10 leading Hydrocortisone exporters from India. 8 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Hydrocortisone sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 200 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The establishment of the Hyderabad Pharma City, spanning over 19,000 acres, aims to further bolster this position by creating a self-sustained ecosystem for pharmaceutical manufacturing and research.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is recognized as a significant hub for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region is home to numerous pharmaceutical companies, including Lincoln Pharmaceuticals Ltd., which is among the top exporters of Hydrocortisone.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Mumbai, being India's financial capital, offers robust infrastructure and connectivity, facilitating the export of pharmaceuticals to various international markets. The region hosts several pharmaceutical companies that contribute significantly to the export of formulations, including Hydrocortisone.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives. The region attracts numerous pharmaceutical companies seeking cost-effective production facilities, thereby contributing to the overall pharmaceutical output of the country.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of suppliers, especially those in Hyderabad and Ahmedabad-Vadodara, to ensure consistent quality and supply.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline logistics and reduce lead times for international shipments.
- Monitor Regulatory Compliance: Stay updated on regulatory changes and ensure that suppliers adhere to the standards set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT).
By strategically sourcing from these clusters and adhering to regulatory standards, TransData Nexus can optimize its supply chain for Hydrocortisone, ensuring reliability and quality in its pharmaceutical offerings.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Hydrocortisone exporters from India
Cipla Limited — Cipla acquires Ivia Beaute's personal care brands
In April 2024, Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore as milestone-based consideration. This acquisition is part of Cipla's strategy to expand its consumer health vertical. - IMPACT: This acquisition is not expected to directly impact Cipla's hydrocortisone exports.
Impact: This acquisition is not expected to directly impact Cipla's hydrocortisone exports.
Cipla Limited — Cipla South Africa acquires Actor Pharma
In September 2023, Cipla South Africa, a subsidiary of Cipla Limited, acquired Actor Pharma, a healthcare products manufacturer based in Midrand, South Africa. - IMPACT: This acquisition may enhance Cipla's distribution network in South Africa, potentially increasing hydrocortisone exports to the region.
Impact: This acquisition may enhance Cipla's distribution network in South Africa, potentially increasing hydrocortisone exports to the region.
Strides Pharma Science Limited — Strides announces creation of OneSource CDMO
In January 2024, Strides Pharma Science Limited announced the creation of OneSource, India's first specialty pharma pure play Contract Development and Manufacturing Organization (CDMO). - IMPACT: This initiative may lead to increased production capacity, potentially boosting hydrocortisone exports.
Impact: This initiative may lead to increased production capacity, potentially boosting hydrocortisone exports.
Common Questions — Hydrocortisone Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which hydrocortisone supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, STRIDES PHARMA SCIENCE LIMITED leads with 115 recorded shipments worth $9.1M. LINCOLN PHARMACEUTICALS LTD (57 shipments) and CIPLA LIMITED (128 shipments) are also established high-volume exporters.
Q How many hydrocortisone manufacturers are there in India?
India has 597 active hydrocortisone exporters with a combined export market of $65.7M across 6,743 shipments to 156 countries. The top 5 suppliers hold 36.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for hydrocortisone from India?
Average FOB unit price: $10.11 per unit, ranging from $0.00 to $7566.25. Average shipment value: $9.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 597 verified Indian exporters of Hydrocortisone ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,743 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 156 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,743 Verified Shipments
597 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists